| Literature DB >> 29951007 |
Kathrin Koch1,2,3, Tim J Reeß1,2,3, Oana G Rus1,2,3,4, Deniz A Gürsel1,2, Gerd Wagner5, Götz Berberich6, Claus Zimmer1.
Abstract
Objective: Obsessive-compulsive disorder (OCD) is characterized by anxiety-provoking, obsessive thoughts (i.e., obsessions) which patients react to with compulsive behaviors (i.e., compulsions). Due to the transient feeling of relief following the reduction of obsession-induced anxiety, compulsions are often described as relieving or even rewarding. Several studies investigated functional activation during reward processing in OCD, but findings are heterogeneous up to now and little is known about potential alterations in functional connectivity. Method: Against this background we studied OCD patients (n = 44) and healthy controls (n = 37) during the receipt of monetary reward by assessing both activation and functional connectivity.Entities:
Keywords: DMN; OCD; connectivity; reinforcement; reward
Year: 2018 PMID: 29951007 PMCID: PMC6008536 DOI: 10.3389/fpsyt.2018.00254
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Demographic and clinical data.
| Sex, male: female | 17:27 | 15:22 | |
| Age, Years | 32.7 (9.3) | 32.0 (8.0) | |
| Medication, yes/no | 32/12 | NA | |
| Medication type | 20 SSRI | ||
| 4 SNRI | |||
| 4 TrA | |||
| 1 Benzo | |||
| 1 Atypic | |||
| 2 no info | |||
| Comorbidities Present/not present | 26/18 | NA | |
| Comorbidity type | 16 depression | ||
| 1 anxiety disorders | |||
| 5 depression & anxiety disorder | |||
| 2 personality disorder | |||
| 1 impulse control | |||
| disorder-not otherwise specified | |||
| Age at onset | 16.23 (6.6) | NA | |
| YBOCS total | 20.0 (6.8) | NA | |
| -Obsessions | 10.5 (3.7) | ||
| -Compulsions | 9.4 (4.2) |
NA, not applicable; SD, standard deviation; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor; TrA, tricyclic antidepressant; Benzo, benzodiazepine; Atypic, Atypical Antipsychotic.
Figure 1Illustration of seeds for the seed-to-voxel functional connectivity analysis. Seeds (red) are based on the activation (blue) from the group comparison (i.e., 6 mm sphere centered on the maximum activated voxel for the contrast controls > patients positive feedback/reward, see also Table 2).
MNI coordinates of activation maxima for the group comparison positive feedback/reward (controls > patients at p < 0.05 corrected) (upper part).
| Superior frontal gyrus, BA8 | L | 352 | 0.031 | −16, 26, 48 |
| Superior frontal gyrus, BA6 | R | 148 | 0.036 | 10, 24, 52 |
| Middle frontal gyrus, BA6 | L | 34 | 0.048 | −38, 8, 54 |
| Middle frontal gyrus, BA8 | R | 28 | 0.046 | 28, 24, 46 |
| PCC, precuneus, BA31 | L | 43 | 0.048 | −20, −60, 24 |
| Precentral gyrus, BA6 | L | 18 | 0.046 | −40, −4, 30 |
| ACC, BA32 | L | 1 | 0.047 | −10, 20, 40 |
| Superior frontal gyrus, medial frontal gyrus, BA10 | L | 1,554 | 0.004 | −6, 60, −6 |
| PCC, BA31 | R | 263 | 0.011 | 4, −52, 22 |
| Medial frontal gyrus, BA10 | L | 1 | 0.031 | −14, 58, 4 |
| ACC, BA32 | R | 1 | 0.041 | 6, 46, 2 |
| Medial frontal gyrus, BA10 | R | 1 | 0.047 | 8, 54, 12 |
MNI coordinates of activation maxima for increased l. PCC (6 mm sphere around maximum activated voxel at x = −20 y = −60 z = 24) connectivity in patients compared to controls for positive feedback/reward (patients > controls at p < 0.05 corrected, lower part). L/R, left/right side; k, number of voxels in cluster; p.
Figure 2Decreased activation in patients compared to controls for positive feedback/reward (see also Table 2).
Figure 3Increased connectivity in patients compared to controls between the left PCC/precuneus (BA31) seed (blue) and left vmPFC (BA10) as well as right PCC (BA31).